{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:16:19Z","timestamp":1778044579363,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203745"],"award-info":[{"award-number":["82203745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Breast cancer (BC) remains the leading cause of global female cancer-related mortality, with poor survival in advanced stages driven largely by metastasis. Ubiquitination, a key post-translational modification, critically regulates the stability and function of various proteins, including oncoproteins and tumor suppressors, and deubiquitinases (DUBs) reversing this process are emerging therapeutic targets. In this study, we report that haploid germ cell-specific nuclear protein kinase (HASPIN) is highly expressed in BC and is closely associated with poor prognosis. We identify the DUB Otubain-2 (OTUB2) as a critical regulator of the oncogenic kinase HASPIN in BC. We demonstrate that OTUB2 binds to and deubiquitylates HASPIN, specifically counteracting its K48-linked polyubiquitination and subsequent proteasomal degradation. Acetylation of HASPIN at lysine 751 by acetyltransferase lysine acetyltransferase 5 (KAT5) enhances its affinity for OTUB2, promoting HASPIN stability. Functionally, OTUB2 depletion reduces HASPIN protein levels, while OTUB2 overexpression-induced HASPIN upregulation drives BC cell proliferation and invasion both in vivo and in vitro. These findings establish OTUB2 as a novel DUB for HASPIN and reveal a previously unknown regulatory axis involving KAT5, acetylation, OTUB2, ubiquitination, and HASPIN, which is crucial for BC progression. Consequently, HASPIN acts as an oncogene in BC and represents a promising new therapeutic target for intervention.<\/jats:p>","DOI":"10.1038\/s41419-026-08658-5","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:47:36Z","timestamp":1774604856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["KAT5-mediated acetylation enhances the deubiquitination of HASPIN by OTUB2 and promotes breast cancer progression"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiani","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuqing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7200-6186","authenticated-orcid":false,"given":"Mingde","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"8658_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8658_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, Cao M, Sun D, He S, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135:584\u201390.","journal-title":"Chin Med J"},{"key":"8658_CR3","doi-asserted-by":"publisher","first-page":"907","DOI":"10.21037\/atm.2020.03.43","volume":"8","author":"K Jazieh","year":"2020","unstructured":"Jazieh K, Bell R, Agarwal N, Abraham J. Novel targeted therapies for metastatic breast cancer. Ann Transl Med. 2020;8:907.","journal-title":"Ann Transl Med"},{"key":"8658_CR4","unstructured":"Street W. Cancer facts & figures 2019. Atlanta, GA, USA: American Cancer Society; 2019."},{"key":"8658_CR5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27:34\u201344.","journal-title":"Nat Med"},{"key":"8658_CR6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/s41571-018-0135-7","volume":"16","author":"B Zhang","year":"2019","unstructured":"Zhang B, Whiteaker JR, Hoofnagle AN, Baird GS, Rodland KD, Paulovich AG. Clinical potential of mass spectrometry-based proteogenomics. Nat Rev Clin Oncol. 2019;16:256\u201368.","journal-title":"Nat Rev Clin Oncol"},{"key":"8658_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605.","journal-title":"Cell Death Differ"},{"key":"8658_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.tcb.2023.09.001","volume":"34","author":"M Loix","year":"2024","unstructured":"Loix M, Zelcer N, Bogie JFJ, Hendriks JJA. The ubiquitous role of ubiquitination in lipid metabolism. Trends Cell Biol. 2024;34:416\u201329.","journal-title":"Trends Cell Biol"},{"key":"8658_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","volume":"86","author":"TET Mevissen","year":"2017","unstructured":"Mevissen TET, Komander D. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem. 2017;86:159\u201392.","journal-title":"Annu Rev Biochem"},{"key":"8658_CR10","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","volume":"93","author":"MJ Clague","year":"2013","unstructured":"Clague MJ, Barsukov I, Coulson JM, Liu H, Rigden DJ, Urb\u00e9 S. Deubiquitylases from genes to organism. Physiol Rev. 2013;93:1289\u2013315.","journal-title":"Physiol Rev"},{"key":"8658_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/10409239891204251","volume":"33","author":"A D\u2019Andrea","year":"1998","unstructured":"D\u2019Andrea A, Pellman D. Deubiquitinating enzymes: a new class of biological regulators. Crit Rev Biochem Mol Biol. 1998;33:337\u201352.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"8658_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrm2731","volume":"10","author":"D Komander","year":"2009","unstructured":"Komander D, Clague MJ, Urb\u00e9 S. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol. 2009;10:550\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8658_CR13","doi-asserted-by":"publisher","first-page":"8782","DOI":"10.2174\/0929867328666210708085544","volume":"28","author":"MA Samy","year":"2021","unstructured":"Samy MA, Abd El Fatah NM, Yahia SE, Arafa RK. Friend or foe: UCHL3 mediated carcinogenesis and current approaches in small molecule inhibitors\u2019 development. Curr Med Chem. 2021;28:8782\u201399.","journal-title":"Curr Med Chem"},{"key":"8658_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116161","volume":"266","author":"LL Zheng","year":"2024","unstructured":"Zheng LL, Wang LT, Pang YW, Sun LP, Shi L. Recent advances in the development of deubiquitinases inhibitors as antitumor agents. Eur J Med Chem. 2024;266:116161.","journal-title":"Eur J Med Chem"},{"key":"8658_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","volume":"147","author":"P D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy P, Wang X, Linder S. Deubiquitinase inhibition as a cancer therapeutic strategy. Pharm Ther. 2015;147:32\u201354.","journal-title":"Pharm Ther"},{"key":"8658_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2013.05.046","volume":"154","author":"TE Mevissen","year":"2013","unstructured":"Mevissen TE, Hospenthal MK, Geurink PP, Elliott PR, Akutsu M, Arnaudo N, et al. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell. 2013;154:169\u201384.","journal-title":"Cell"},{"key":"8658_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tibs.2010.09.006","volume":"36","author":"SS Taylor","year":"2011","unstructured":"Taylor SS, Kornev AP. Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem Sci. 2011;36:65\u201377.","journal-title":"Trends Biochem Sci"},{"key":"8658_CR18","doi-asserted-by":"publisher","first-page":"20204","DOI":"10.1073\/pnas.0908485106","volume":"106","author":"F Villa","year":"2009","unstructured":"Villa F, Capasso P, Tortorici M, Forneris F, de Marco A, Mattevi A, et al. Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization. Proc Natl Acad Sci USA. 2009;106:20204\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8658_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.drudis.2017.10.005","volume":"23","author":"NG Amoussou","year":"2018","unstructured":"Amoussou NG, Bigot A, Roussakis C, Robert J-MH. Haspin: a promising target for the design of inhibitors as potent anticancer drugs. Drug Discov Today. 2018;23:409\u201315.","journal-title":"Drug Discov Today"},{"key":"8658_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.111605","volume":"385","author":"X Han","year":"2019","unstructured":"Han X, Kuang T, Ren Y, Lu Z, Liao Q, Chen W. Haspin knockdown can inhibit progression and development of pancreatic cancer in vitro and vivo. Exp Cell Res. 2019;385:111605.","journal-title":"Exp Cell Res"},{"key":"8658_CR21","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.18632\/aging.103005","volume":"12","author":"Y Chen","year":"2020","unstructured":"Chen Y, Fu D, Zhao H, Cheng W, Xu F. GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12). Aging. 2020;12:8858\u201379.","journal-title":"Aging"},{"key":"8658_CR22","doi-asserted-by":"crossref","unstructured":"Zhou J, Nie W, Yuan J, Zhang Z, Mi L, Wang C, et al. GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration. Oncol Rep. 2021;45:91.","DOI":"10.3892\/or.2021.8042"},{"key":"8658_CR23","doi-asserted-by":"crossref","unstructured":"Hadders MA, Hindriksen S, Truong MA, Mhaskar AN, Wopken JP, Vromans MJM, et al. Untangling the contribution of Haspin and Bub1 to Aurora B function during mitosis. J Cell Biol. 2020;219:e201907087.","DOI":"10.1083\/jcb.201907087"},{"key":"8658_CR24","doi-asserted-by":"publisher","first-page":"4508","DOI":"10.1002\/jcp.29328","volume":"235","author":"P Wang","year":"2020","unstructured":"Wang P, Hua X, Bryner YH, Liu S, Gitter CB, Dai J. Haspin inhibition delays cell cycle progression through interphase in cancer cells. J Cell Physiol. 2020;235:4508\u201319.","journal-title":"J Cell Physiol"},{"key":"8658_CR25","doi-asserted-by":"crossref","unstructured":"Tang Y, Dai G, Yang Y, Liu H. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1. J Transl Med. 2023;21:523.","DOI":"10.1186\/s12967-023-04358-2"},{"key":"8658_CR26","doi-asserted-by":"crossref","unstructured":"Quadri R, Sertic S, Muzi-Falconi M. Roles and regulation of Haspin kinase and its impact on carcinogenesis. Cell Signal. 2022;93:110303.","DOI":"10.1016\/j.cellsig.2022.110303"},{"key":"8658_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2020.111863","volume":"390","author":"D Zhu","year":"2020","unstructured":"Zhu D, Gu X, Lin Z, Yu D, Wang J, Li L. HASPIN is involved in the progression of gallbladder carcinoma. Exp Cell Res. 2020;390:111863.","journal-title":"Exp Cell Res"},{"key":"8658_CR28","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/CMAR.S274807","volume":"13","author":"Y Huang","year":"2021","unstructured":"Huang Y, Liu Y, Zhu K, Ma X, Lu R, Zhang M. GSG2 Promotes development and predicts poor prognosis of ovarian cancer. Cancer Manag Res. 2021;13:499\u2013508.","journal-title":"Cancer Manag Res"},{"key":"8658_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.devcel.2006.09.018","volume":"11","author":"J Dai","year":"2006","unstructured":"Dai J, Sullivan BA, Higgins JM. Regulation of mitotic chromosome cohesion by Haspin and Aurora B. Dev Cell. 2006;11:741\u201350.","journal-title":"Dev Cell"},{"key":"8658_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cub.2011.05.016","volume":"21","author":"F Wang","year":"2011","unstructured":"Wang F, Ulyanova NP, van der Waal MS, Patnaik D, Lens SM, Higgins JM. A positive feedback loop involving Haspin and Aurora B promotes CPC accumulation at centromeres in mitosis. Curr Biol. 2011;21:1061\u20139.","journal-title":"Curr Biol"},{"key":"8658_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1126\/science.1189435","volume":"330","author":"F Wang","year":"2010","unstructured":"Wang F, Dai J, Daum JR, Niedzialkowska E, Banerjee B, Stukenberg PT, et al. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science. 2010;330:231\u20135.","journal-title":"Science"},{"key":"8658_CR32","doi-asserted-by":"crossref","unstructured":"Quadri R, Sertic S, Ghilardi A, Rondelli D, Gallo GR, Del Giacco L, et al. Phosphorylation of H3-Thr3 by Haspin is required for primary cilia regulation. Int J Mol Sci. 2021;22:7753.","DOI":"10.3390\/ijms22147753"},{"key":"8658_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.devcel.2013.07.013","volume":"26","author":"D Panigada","year":"2013","unstructured":"Panigada D, Grianti P, Nespoli A, Rotondo G, Castro DG, Quadri R, et al. Yeast haspin kinase regulates polarity cues necessary for mitotic spindle positioning and is required to tolerate mitotic arrest. Dev Cell. 2013;26:483\u201395.","journal-title":"Dev Cell"},{"key":"8658_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41421-020-0170-2","volume":"6","author":"R Quadri","year":"2020","unstructured":"Quadri R, Galli M, Galati E, Rotondo G, Gallo GR, Panigada D, et al. Haspin regulates Ras localization to promote Cdc24-driven mitotic depolarization. Cell Discov. 2020;6:42.","journal-title":"Cell Discov"},{"key":"8658_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.embor.7400201","volume":"5","author":"MH Nanao","year":"2004","unstructured":"Nanao MH, Tcherniuk SO, Chroboczek J, Dideberg O, Dessen A, Balakirev MY. Crystal structure of human otubain 2. EMBO Rep. 2004;5:783\u20138.","journal-title":"EMBO Rep"},{"key":"8658_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.820781","volume":"10","author":"J Li","year":"2022","unstructured":"Li J, Zhang N, Li M, Hong T, Meng W, Ouyang T. The emerging role of OTUB2 in diseases: from cell signaling pathway to physiological function. Front Cell Dev Biol. 2022;10:820781.","journal-title":"Front Cell Dev Biol"},{"key":"8658_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, et al. OTUB2 promotes cancer metastasis via hippo-independent activation of YAP and TAZ. Mol Cell. 2019;73:7\u201321.e7.","journal-title":"Mol Cell"},{"key":"8658_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/CMAR.S184781","volume":"11","author":"Y Ma","year":"2019","unstructured":"Ma Y, Sun Y. miR-29a-3p inhibits growth, proliferation, and invasion of papillary thyroid carcinoma by suppressing NF-\u03baB signaling via direct targeting of OTUB2. Cancer Manag Res. 2019;11:13\u201323.","journal-title":"Cancer Manag Res"},{"key":"8658_CR39","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/kjm2.12187","volume":"36","author":"ZL Gu","year":"2020","unstructured":"Gu ZL, Huang J, Zhen LL. Knockdown of otubain 2 inhibits liver cancer cell growth by suppressing NF-\u03baB signaling. Kaohsiung J Med Sci. 2020;36:399\u2013404.","journal-title":"Kaohsiung J Med Sci"},{"key":"8658_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, et al. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9:179\u201395.","journal-title":"Theranostics"},{"key":"8658_CR41","first-page":"5382","volume":"13","author":"X Xu","year":"2023","unstructured":"Xu X, Wu G, Han K, Cui X, Feng Y, Mei X, et al. Inhibition of OTUB2 suppresses colorectal cancer cell growth by regulating \u03b2-Catenin signaling. Am J Cancer Res. 2023;13:5382\u201393.","journal-title":"Am J Cancer Res"},{"key":"8658_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12195-022-00720-4","volume":"15","author":"G Hu","year":"2022","unstructured":"Hu G, Yang J, Zhang H, Huang Z, Yang H. OTUB2 promotes proliferation and migration of hepatocellular carcinoma cells by PJA1 deubiquitylation. Cell Mol Bioeng. 2022;15:281\u201392.","journal-title":"Cell Mol Bioeng"},{"key":"8658_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-022-00169-9","volume":"24","author":"L Liu","year":"2022","unstructured":"Liu L, Cheng H, Ji M, Su L, Lu Z, Hu X, et al. OTUB2 regulates YAP1\/TAZ to promotes the progression of esophageal squamous cell carcinoma. Biol Proced Online. 2022;24:10.","journal-title":"Biol Proced Online"},{"key":"8658_CR44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","volume":"41","author":"S Yu","year":"2022","unstructured":"Yu S, Zang W, Qiu Y, Liao L, Zheng X. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and glycolysis. Oncogene. 2022;41:46\u201356.","journal-title":"Oncogene"},{"key":"8658_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01789-2","volume":"22","author":"W Zhu","year":"2024","unstructured":"Zhu W, Wu C, Liu Z, Zhao S, Huang J. OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression. Cell Commun Signal. 2024;22:420.","journal-title":"Cell Commun Signal"},{"key":"8658_CR46","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315348121","volume":"121","author":"Y Nan","year":"2024","unstructured":"Nan Y, Wu X, Luo Q, Chang W, Zhao P, Zhang L, et al. OTUB2 silencing promotes ovarian cancer via mitochondrial metabolic reprogramming and can be synthetically targeted by CA9 inhibition. Proc Natl Acad Sci USA. 2024;121:e2315348121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8658_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111561","volume":"41","author":"W Chang","year":"2022","unstructured":"Chang W, Luo Q, Wu X, Nan Y, Zhao P, Zhang L, et al. OTUB2 exerts tumor-suppressive roles via STAT1-mediated CALML3 activation and increased phosphatidylserine synthesis. Cell Rep. 2022;41:111561.","journal-title":"Cell Rep"},{"key":"8658_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44466-7","volume":"15","author":"W Ren","year":"2024","unstructured":"Ren W, Xu Z, Chang Y, Ju F, Wu H, Liang Z, et al. Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1. Nat Commun. 2024;15:9.","journal-title":"Nat Commun"},{"key":"8658_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-021-00827-7","volume":"29","author":"P Liu","year":"2022","unstructured":"Liu P, Cong X, Liao S, Jia X, Wang X, Dai W, et al. Global identification of phospho-dependent SCF substrates reveals a FBXO22 phosphodegron and an ERK-FBXO22-BAG3 axis in tumorigenesis. Cell Death Differ. 2022;29:1\u201313.","journal-title":"Cell Death Differ"},{"key":"8658_CR50","doi-asserted-by":"crossref","unstructured":"Valencia-S\u00e1nchez MI, De Ioannes P, Wang M, Truong DM, Lee R, Armache JP, et al. Regulation of the Dot1 histone H3K79 methyltransferase by histone H4K16 acetylation. Science. 2021;371:eabc6663.","DOI":"10.1126\/science.abc6663"},{"key":"8658_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900739","volume":"7","author":"C Liu","year":"2020","unstructured":"Liu C, Zhao H, Xiao S, Han T, Chen Y, Wang T, et al. Slx5p-Slx8p promotes accurate chromosome segregation by mediating the degradation of synaptonemal complex components during meiosis. Adv Sci (Weinh). 2020;7:1900739.","journal-title":"Adv Sci (Weinh)"},{"key":"8658_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2023.194944","volume":"1866","author":"A Ghosh","year":"2023","unstructured":"Ghosh A, Chakraborty P, Biswas D. Fine tuning of the transcription juggernaut: a sweet and sour saga of acetylation and ubiquitination. Biochim Biophys Acta Gene Regul Mech. 2023;1866:194944.","journal-title":"Biochim Biophys Acta Gene Regul Mech"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08658-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08658-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:03:27Z","timestamp":1778043807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08658-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8658"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08658-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"411"}}